An industry expert discusses how emerging artificial intelligence technologies might shape the healthcare landscape.
Artificial intelligence (AI) is rapidly spreading throughout the realm of medtech as companies from every corner of the market look to adapt to the latest in innovation. Whether you’re an industry giant, or a shiny new startup, advancements in AI technologies are forcing companies to embrace and adapt to new developments—all while altering the medtech landscape in the process.
So what’s new with artificial intelligence? How are companies beginning to tap their potential, and when will we begin to actually see the impact they can have on the world of healthcare? These are some of the questions that Gioel Molinari will be addressing at next month’s MD&M East 2018 conference in New York, where he’ll be part of a panel discussion on the topic of “How Artificial Intelligence is Moving the Needle in Medtech.”
Molinari is the current president of Butterfly Network Inc., a cutting-edge technology company that focuses on semiconductor technologies, cloud platforms, and artificial intelligence and deep learning technologies that can shape next-gen devices. Recently the company has been working on a new diagnostic ultrasound technology, known as the Butterfly IQ, that uses a chip technology to transform any smartphone into an ultrasound imaging tool.
Molinari has spent the better part of the last decade monitoring the latest in AI and deep learning developments, with a specific eye on the impact they’ll have on both healthcare and the realm of medical device development. To that end, we decided to sit down with Molinari ahead of his panel discussion to get a better idea on how AI technologies are moving the needle in medtech, and what companies need to do to adapt to the changes and keep up.
Image Credit: Zapp2Photo/Shutterstock